AstraZeneca Files Patent Infringement Suit Against Teva Over Seroquel

Drug Industry Daily
KEYWORDS courts / Patents
A A

AstraZeneca has initiated a patent infringement lawsuit challenging Teva Pharmaceutical’s bid to launch a generic version of AstraZeneca’s blockbuster schizophrenia treatment Seroquel (quetiapine fumarate).

To View This Article:

Login

Subscribe To Drug Industry Daily